Buradasınız

Anasayfa » Content

A STUDY OF MAGNESIUM SUPPLEMENTATION ON FASTING BLOOD GLUCOSE IN PATIENTS OF DIABETES MELLITUS TYPE-2

Journal Name:

  • The International Journal of Pharmaceutical Research and Bio-Science

Publication Year:

  • 2013

Key Words:

Author Name
Abstract (2. Language): 
The study was done in 60 diabetic patients. These patients were divided into two groups, Group I (n=30) receiving Magnesium and Metformin therapy for a period of 16 weeks and Group II (n=30) receiving only Metformin therapy. The blood samples were collected and analyzed for Serum Magnesium and fasting blood glucose at 0, 4, 8, 16 weeks respectively. In GROUP I Mean Baseline value for S. Magnesium is 1.79±0.032 and after treatment values at 16 weeks 1.92±0.034. In this group we observed that S. Magnesium values before and after 16 weeks of magnesium supplementation was highly significant. In GROUP II Mean Baseline value for S. Magnesium is 1.79±0.031 and after treatment values at 16 weeks is 1.82±0.030. In this group there was no significant difference in S. Magnesium between before and after 16 weeks of treatment. In our study values for Mean fasting blood glucose level in group I before treatment (i.e. first visit) was 146.33±1.60 mg/dl as compared to 127.07±0.96 mg/dl values of after treatment. This difference was considered highly Significant between before and after treatment values for fasting blood glucose levels (p<0.001)In group II values for mean fasting blood glucose level before treatment (i.e. first visit) was 145.5±1.81 mg/dl as compared to 136.53±1.31 mg/dl values of fasting blood glucose after treatment. This Difference was also considered Significant.
Bookmark/Search this post with
FULL TEXT (PDF): 
PDF icon ijprbs_245.pdf
  • 2
1-10
  • English

REFERENCES

References: 

1. Ma J, Folsom AR, Melnick SL, Eckfeldt JH, Sharrett AR, Nabulsi AA, Hutchinson RG and Metcalf PA: Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid wall thickness: the ARIC study. J Clin Epidemiol 1985, 48: 927-940
2. Elamin A, Tuvemo T. Magnesium and insulin-dependent diabetes mellitus. Diabetes Res Clin Pract. 1990; 10(3): 203-9.
3. De Valk HW. Magnesium in diabetes
mellitus. Neth J Med. 1999; 54(4): 139-46.
4. Rosolova H., O. Mayer, Jr, and G.M. Reaven. Department of Internal Medicine, Medical Faculty, Charles University Pilsen, Center of Preventive Medicine, Pilsen, Czech Republic, Stanford University School of Medicine, Stanford, CA, USA. Insulin-mediated glucose disposal is decreased in normal subjects with relatively low plasma
Available Online At www.ijprbs.com
Research Article
Ashutosh Bhardwaj, IJPRBS, 2013; Volume 2(2):
1-10
ISSN: 2277-8713
IJPRBS
magnesium concentrations. Metabolism Volume 49, Issue 3, March 2000, 418-420.
5. Luis E Simental-Mendfa, Martha Rodriguez-Moran, Fernando Guerrero-Romero. Failure of |3-cell function for compensate variation in insulin sensitivity in hypomagnesemic subjects. Magnesium
Research. 2009; 22 (3),151-156
6. Yiqing Song, Jo Ann E. Manson, Julie E. Buring, Simin Liu. Dietary Magnesium Intake in Relation to Plasma Insulin Levels and Risk of Type 2 Diabetes in Women Dietary Magnesium Intake in Relation to Plasma Insulin Levels and Risk of Type 2 Diabetes in Women Diabetes Care, 2004 27:59-65.
7. Hasanein P. et al. Oral magnesium administration prevents thermal hyperalgesia induced by diabetes in rats. Department of Biology, Bu-Ali Sina University, Hamadan, Iran. Diabetes Res Clin Pract. 2006; 14.
8. Sales CH, Pedrosa Lde F. Sales CH, Pedrosa Lde F. Relation between magnesium and diabetes. Clin Nutr. 2006;
25(4):554-62.
9. Phuong-Chi T. Pham, Phuong-Mai T. Pham, Son V. Pham, Jeffrey M. Miller, and
Phuong-Thu T. Pham. Hypomagnesaemia in Patients with Type 2 Diabetes. Clin J Am Soc Nephrol .2007; 2: 366-373, © 2007 American Society of Nephrology doi:
10.2215/CJN.02960906.
10. Low serum magnesium levels and foot ulcers in subjects with type 2 diabetes. Rodriguez-Moran M, Guerrero-Romero F.
Arch Med Res. 2001; 32(4): 300-3.
11. Song Y, He K, Levitan EB, Manson JE, Liu S. Effects of oral magnesium supplementation on glycaemic control in Type 2 diabetes: a meta-analysis of randomized double-blind controlled trials. Diabet Med. 2006; 23(10): 1050-6.
12. Guerrero-Romero F, Tamez-Perez HE, Gonzalez-Gonzalez G et al. Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial. Diabetes
Metab. 2004; 30(3): 253-8.
13. Ka He, MD, ScD; Kiang Liu, PhD; Martha L. Daviglus, MD, PhD; Steven J. Morris, PhD; Catherine M. Loria, PhD; Linda Van Horn, PhD; David R. Jacobs, Jr, PhD; Peter J. Savage, MD. Magnesium Intake and Incidence of Metabolic Syndrome Among
Available Online At www.ijprbs.com
Research Article
Ashutosh Bhardwaj, IJPRBS, 2013; Volume 2(2): 1-10
Young Adults Circulation. 2006; 113: 1675© 2006 American Heart Association, Inc.
14. Chaudhary DP, Sharma R, Bansal DD, Department of Plant Breeding and Genetics,
ISSN: 2277-8713 IJPRBS
Punjab Agricultural University, Ludhiana. Implications of magnesium deficiency in type 2 diabetes: a review. Biol Trace Elem
Res. 2010; 134(2):119-29.
Available Online

Thank you for copying data from http://www.arastirmax.com